arrow_back Back to App

Boosting Brain Tumor Research and Care: New Programs and Information Access.

This act aims to accelerate brain tumor research and improve access to specialized care. Citizens will gain better access to information on clinical trials and treatment options, as well as support for post-treatment care.
Key points
Increased transparency of brain tumor biospecimen data, facilitating researchers' access to study materials.
New research programs and funding for innovative therapies, including immunotherapy, for brain tumor patients.
A national public awareness campaign to increase knowledge about cancer clinical trials and biomarker testing, including for brain tumors.
Pilot programs to support lifelong monitoring and care for brain tumor survivors.
FDA guidance to ensure brain tumor patients' access to clinical trials for other conditions.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_2767
Sponsor: Rep. Fitzpatrick, Brian K. [R-PA-1]
Process start date: 2025-04-09
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

BRAIN Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_2767.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-04-09.

What are the main provisions?

Key points include:

  • Increased transparency of brain tumor biospecimen data, facilitating researchers' access to study materials.
  • New research programs and funding for innovative therapies, including immunotherapy, for brain tumor patients.
  • A national public awareness campaign to increase knowledge about cancer clinical trials and biomarker testing, including for brain tumors.
  • Pilot programs to support lifelong monitoring and care for brain tumor survivors.
  • FDA guidance to ensure brain tumor patients' access to clinical trials for other conditions.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Fitzpatrick, Brian K. [R-PA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health